Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Psychosis: Goals of Pharmacotherapy01:26

Psychosis: Goals of Pharmacotherapy

706
Antipsychotic drugs are a crucial treatment method for acute and chronic psychoses, bipolar illness, and behavioral disorders. The selection of these drugs depends on several factors, including the state of the disease, clinical judgment, possible drug interactions, and the patient's sensitivity to adverse effects. In immediate scenarios, such as delirium and dementia, short-term treatment with low doses of high-potency typical or atypical agents can effectively manage symptom exacerbation.
706
Alzheimer's Disease: Treatment01:22

Alzheimer's Disease: Treatment

1.3K
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
1.3K
Pericarditis III: Medical Management01:17

Pericarditis III: Medical Management

586
The primary objectives of managing pericarditis are to determine the underlying cause, provide effective therapy for treatment and symptom relief, and promptly detect signs and symptoms of cardiac tamponade. The following outlines the essential aspects of medical management for pericarditis:ObjectivesDetermine the Cause: Identifying the underlying cause of pericarditis is crucial for targeted treatment. Causes include viral infections, autoimmune diseases, post-cardiac injury syndrome, and...
586
Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

632
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
632
Healing I: Introduction01:11

Healing I: Introduction

14
Healing is the physiological process by which the body restores the integrity and function of damaged tissues following injury. It involves a coordinated interplay of cellular proliferation, extracellular matrix remodeling, and growth factor signaling. The extent and nature of the tissue damage determine whether healing occurs by resolution, regeneration, or replacement.ResolutionResolution represents the most complete form of healing, occurring when the injury is minimal and tissue...
14
Healing II: Complications01:24

Healing II: Complications

37
Complications during healing arise when tissue repair is altered by local or systemic factors. These changes involve abnormal collagen deposition, altered biomechanics, and reduced vascular supply, impairing restoration of normal structure and function.Loss of FunctionScar tissue differs significantly from the original tissue it replaces. In the skin, fibrosis lacks adnexal structures such as hair follicles, sebaceous glands, and sweat glands. Their absence reduces tactile sensitivity, impairs...
37

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same authorSame journal

Our commitment to early-career clinicians and academics.

Lancet (London, England)·2026
Same author

Daniel Mason: a tale of change.

Lancet (London, England)·2026
Same author

The Lancet Commission on rethinking misinformation, health, and human security.

Lancet (London, England)·2026
Same author

What can psychiatrists expect from the next DSM?

Lancet (London, England)·2026
Same author

Tarun Khanna: entrepreneur of social change.

Lancet (London, England)·2026
Same author

Rachel Clarke: writing life.

Lancet (London, England)·2026

Related Experiment Video

Updated: May 5, 2026

The NeuroStar TMS Device: Conducting the FDA Approved Protocol for Treatment of Depression
10:29

The NeuroStar TMS Device: Conducting the FDA Approved Protocol for Treatment of Depression

Published on: November 13, 2010

43.5K

Kay Redfield Jamison: healing in mind

Niall Boyce

    Lancet (London, England)
    |July 23, 2023
    PubMed
    Summary

    No abstract available in PubMed .

    More Related Videos

    Rodent Heart and Brain Tissue Preparation for Digital Macro Photography after Ischemia-reperfusion
    06:27

    Rodent Heart and Brain Tissue Preparation for Digital Macro Photography after Ischemia-reperfusion

    Published on: February 1, 2022

    5.7K
    Improved Rodent Model of Myocardial Ischemia and Reperfusion Injury
    07:23

    Improved Rodent Model of Myocardial Ischemia and Reperfusion Injury

    Published on: March 7, 2022

    8.8K

    Related Experiment Videos

    Last Updated: May 5, 2026

    The NeuroStar TMS Device: Conducting the FDA Approved Protocol for Treatment of Depression
    10:29

    The NeuroStar TMS Device: Conducting the FDA Approved Protocol for Treatment of Depression

    Published on: November 13, 2010

    43.5K
    Rodent Heart and Brain Tissue Preparation for Digital Macro Photography after Ischemia-reperfusion
    06:27

    Rodent Heart and Brain Tissue Preparation for Digital Macro Photography after Ischemia-reperfusion

    Published on: February 1, 2022

    5.7K
    Improved Rodent Model of Myocardial Ischemia and Reperfusion Injury
    07:23

    Improved Rodent Model of Myocardial Ischemia and Reperfusion Injury

    Published on: March 7, 2022

    8.8K